Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital

Journal of the Medical Association of Thailand

Volumn 97, Issue 3 SUPPL. 3, 2014, Pages

  Chaisathaphol, Thanet ^a   Chayakulkeeree, Methee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Drug resistance; Epidemiology; Gram negative bacteria; Multi drug resistant

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BACTERIAL INFECTION; CITROBACTER FREUNDII; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DOSE CALCULATION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG USE; ENTEROBACTER CLOACAE; ENTEROBACTER KOSERI; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; HEMATOLOGIC DISEASE; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PREVALENCE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; THERAPEUTIC ERROR; TREATMENT OUTCOME; WOUND DRESSING; ACINETOBACTER INFECTION; AGED; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GRAM NEGATIVE INFECTION; HOSPITALIZATION; METABOLISM; PSEUDOMONAS INFECTION; THAILAND; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSEUDOMONAS INFECTIONS; RISK FACTORS; THAILAND;

EID: 84900026595     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Moreira MR, Guimaraes MP, Rodrigues AA, Gontijo Filho PP. Antimicrobial use, incidence, etiology and resistance patterns in bacteria causing ventilator-associated pneumonia in a clinicalsurgical intensive care unit. Rev Soc Bras Med Trop 2013; 46: 39-44.
2. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005; 26: 463-72.
3. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000; 3: 303-11.
4. Wei C, Cheng Z, Zhang L, Yang J. Microbiology and prognostic factors of hospital-and community-acquired aspiration pneumonia in respiratory intensive care unit. Am J Infect Control 2013; 41: 880-4.
5. Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, Koh TH. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010; 54: 1173-8.
6. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010; 362: 1804-13.
7. Danchaivijitr S, Judaeng T, Sripalakij S, Naksawas K, Plipat T. Prevalence of nosocomial infection in Thailand 2006. J Med Assoc Thai 2007; 90: 1524-9.
8. Liew YX, Lee W, Loh JC, Cai Y, Tang SS, Lim CL, et al. Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital. Int J Antimicrob Agents 2012; 40: 55-60.
9. Moro ML, Ricchizzi E, Morsillo F, Marchi M, Puro V, Zotti CM, et al. Infections and antimicrobial resistance in long term care facilities: a national prevalence study. Ann Ig 2013; 25: 109-18.
10. Rattanaumpawan P, Sutha P, Thamlikitkul V. Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures. Am J Infect Control 2010; 38: 38-43.
11. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
12. Park SC, Kang YA, Park BH, Kim EY, Park MS, Kim YS, et al. Poor prediction of potentially drugresistant pathogens using current criteria of health care-associated pneumonia. Respir Med 2012; 106: 1311-9.
13. Park SC, Kim EY, Kang YA, Park MS, Kim YS, Kim SK, et al. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients. Int J Tuberc Lung Dis 2013; 17: 704-9.
14. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health careassociated pneumonia. Arch Intern Med 2008; 168: 2205-10.
15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
16. Abhilash KP, Veeraraghavan B, Abraham OC. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. J Assoc Physicians India 2010; 58 (Suppl): 13-7.
17. Metri BC, Jyothi P, Peerapur BV. The Prevalence of ESBL among Enterobacteriaceae in a tertiary care hospital of North Karnataka, India. J Clin Diagn Res 2011; 5: 470-75.
18. Maraki S, Mavros MN, Kofteridis DP, Samonis G, Falagas ME. Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gramnegative bacilli isolated from patients treated on surgical wards. Surg Infect (Larchmt) 2012; 13: 326-31.
19. Jitsurong S, Yodsawat J. Prevalence of extendedspectrum beta-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand. Southeast Asian J Trop Med Public Health 2006; 37: 131-5.
20. Dejsirilert S, Tiengrim S, Sawanpanyalert P, Aswapokee N, Malathum K. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. J Med Assoc Thai 2009; 92 (Suppl 4): S34-45.
21. Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, et al. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. J Med Assoc Thai 2009; 92 (Suppl 4): S68-75.
22. Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagace-Wiens P, et al. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother 2010; 54: 4684-93.
23. Anunnatsiri S, Towiwat P, Chaimanee P. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. Southeast Asian J Trop Med Public Health 2012; 43: 1169-77.
24. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, et al. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 2010; 38: 33-40.
25. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, et al. Risk factors for increasing multidrug resistance among extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis 2005; 40: 1317-24.
26. Forslund K, Sunagawa S, Kultima JR, Mende DR, Arumugam M, Typas A, et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res 2013; 23: 1163-9.
27. Hildreth CJ, Burke AE, Glass RM. JAMA patient page. Inappropriate use of antibiotics. JAMA 2009; 302: 816.
28. Liu YC, Huang WK, Huang TS, Kunin CM. Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan. Arch Intern Med 2001; 161: 2366-70.
29. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi DC, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012; 38: 1930-45.
30. Caini S, Hajdu A, Kurcz A, Borocz K. Hospitalacquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill 2013; 18. doi: pii: 20352.
31. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162: 678-84.
32. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012; 67: 742-8.